Home
Products and Services
News
Technology
Publications
Investors & Strategic Partners
Our Team
Contact
Legal

 

 

Featured Products:Palpator™ High Throughput Device

 

 

Mini-Construct Chamber™

 

InvivoSciences and Myomics Announce Partnership

View Press Release

 

GCI Magazine – Global Cosmetic Industry

 

InvivoSciences provides alternatives to animal testing for the cosmetic and consumer goods industries

GCI link

 

Injecting New Life into Cell-Based Assays – GEN Sep 2011

 

Late-Stage Drug Failures Prompt Push for More Effective Approaches to Designing Therapies

View Article

 

InvivoSciences sponsors 2nd Annual Cell-Based Assays by Visiongain – London, UK (October 11-13th) –

Conference Website

 

Optimising methods and integrating new platforms for drug discovery, development and toxicity testing

 

Cell-Based Assays Move to Fore – GEN Feb 2011

 

Advances in cell-based assays aim to detect more subtle toxicities often not seen until later-stage drug screening.

View Article

 

Rave Reviews From Minnesota Companies – Positively Minnesota

 

BIO International Convention Rave Reviews

Executives express the benefits of the BIO Organization

 

A Fund For Women (AFFW) – 2011 Winter Newsletter

View Newsletter here

 

Global Discovery & Development Innovation Leaders Summit – Orlando, FL (Nov. 8-9th, 2010) –

 

GDDIS Programme

The annual summit focuses on the advance of drug discovery through scientific innovation & strategy. InvivoSciences LLC, among other sponsors, will lead a talk on Engineered Tissue Based-Drug Discovery

 

NIH SBIR/STTR Phase II Grant –

InvivoSciences was awarded with Phase II Grant for engineered tissue-based, high-throughput compound profiling.

 

This project focuses on developing a novel high-throughput screening platform for drug discovery in cardiac fibrosis area that measures the physiological properties of live, engineered tissue samples, and their controls, cultured in 96-well format (the Palpator™ system).

 

Cell-Based Assays Conference by Visiongain – London, UK (Sept 20-22nd, 2010) –

 

Cell-Based Assays Conference Overview

Hilton London Olympia will host Visiongain's Cell-Based Assays conference. InvivoSciences' Chief Scientific Officer, Dr. Tetsuro Wakatsuki, will speak on 3D cell culture systems and their applications in drug discovery and beyond.

 

BioForward Awards Scholarships for BIO2010 International Convention –

 

InvivoSciences LLC has been invited by BIO to present again during BIO2010 at Chicago. Come and see our presentation May 5th at 3pm in Room C or visit us at Booth #4307.

 

Bioforward Small Business Scholarship Awards

 

BioPharma Dealmakers – Nature Biotechnology - Jan 2010 –

See p.25 (S23) for feature article on InvivoSciences LLC

 

American Society for Cell Biology – SAN DIEGO, CALIFORNIA (December 5-9th, 2009) –

 

December 5-9th, InvivoSciences, LLC displayed its products and technology at the American Society for Cell Biology's 49th Annual Meeting. The ASCB conference attracts scientists and students in academia, industry and the government from the U.S. as well as internationally.

 

Lt. Governor Barbara Lawton Commends Wauwatosa Biotechnology Company InvivoSciences for National and State Awards – MADISON, WI (November 4, 2009) –

 

Lieutenant Governor Barbara Lawton today commended InvivoSciences LLC., a women-led bioscience company based in Wauwatosa, for its selection as one of the top three most promising technologies in the United States at the Worlds Best Technology Showcase (WBTshowcase) in Arlington, Texas. Investors, licensing scouts and tech-commercialization experts from across the country selected InvivoSciences from a pool of 450 technology companies to receive its gold prize. InvivoSciences earned additional recognition last month when Bioforward selected it as the winner of its 2009 Emerging Biotechnology Showcase.

 

BioForward - MADISON/MILWAUKEE, WI (October 7, 2009) –

 

Invivosciences LLC received its Emerging Technology Award from Dick Leinenkugel, Wisconsin Secretary of the Department of Commerce, during BioForward Wisconsin Vision 2010 summit.

 

MADISON/MILWAUKEE, Wisc. (September 21, 2009) –

 

InvivoSciences, LLC was recently selected as a winner of the Emerging Company Showcase awarded by BioForward of Wisconsin. The company was one of six companies to receive this scholarship award to represent Wisconsin at the Biotechnology Vision Summit on October 7, 2009 at the Madison Marriott West hotel.

 

For more information, view the following announcements:


The Medical News:
http://www.news-medical.net/news/20090922/Winners-of-the-2009-Biotechnology-Vision-Summits-Emerging-Company-Showcase-announced.aspx

WTN News:
http://wistechnology.com/articles/6544/

Milwaukee Journal Sentinel
http://www.jsonline.com/business/59998582.html

 

MADISON, Wisc. (June 9, 2009) –

 

Ayla Annac, co-founder, president and CEO of InvivoSciences, was named Executive of the Week on June 9, 2009 by http://www.ibmadison.com/. For more information, visit: http://ibmadison.com/ed-profile?executive_id=27106.

 

Arlington-DFW (March 24-25, 2009) WBT showcase –

 

InvivoSciences joined over 100 investors and licensees to present its technology and business model at the World's Best Technology showcase in Texas on Mar 24-25. InvivoSciences was among the top 3 award winners at the showcase. The company was selected by investors, licensees, and tech-commercialization experts to receive the "gold" award.

 

State Journal

 

 

BOSTON, Mass. (August 11-23, 2008) –

 

The Chief Scientific Officer of InvivoSciences was invited to talk about IVS' technology at the Cellutions SUMMIT in Boston (Aug 11-13). His presentation on Aug 12 was entitled "Engineered Heart Tissue Based High Throughput Phenotyping and Toxicology Testing for Drug Discovery."

 

 

SAN DIEGO, Calif. (June 17-20, 2008) – MADISON/MILWAUKEE

 

One of 14 Wisconsin companies chosen to present at the International BioForum, InvivoSciences attracted interest from nearly two dozen Fortune 500 companies and several forward-thinking investors to its June 19 presentation at the San Diego Convention Center.